within Pharmacolibrary.Drugs.ATC.G;

model G03XB51
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.69,
    Cl             = 3.5000000000000004e-05,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600,            
    Vdp             = 0.12,
    k12             = 10,
    k21             = 10
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03XB51</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Mifepristone is a synthetic steroid with potent antiprogestational and antiglucocorticoid activities, often used in combination with a prostaglandin analogue to terminate early pregnancy. The combination is referred by ATC code G03XB51. Mifepristone is currently approved for medical abortion in several countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical healthy adult female population after oral single dose, as no specific population PK model describing G03XB51 combinations was found in the literature.</p><h4>References</h4><ol><li><p>Heikinheimo, O (1997). Clinical pharmacokinetics of mifepristone. <i>Clinical pharmacokinetics</i> 33(1) 7–17. DOI:<a href=\"https://doi.org/10.2165/00003088-199733010-00002\">10.2165/00003088-199733010-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9250420/\">https://pubmed.ncbi.nlm.nih.gov/9250420</a></p></li><li><p>Sarkar, NN (2002). Mifepristone: bioavailability, pharmacokinetics and use-effectiveness. <i>European journal of obstetrics, gynecology, and reproductive biology</i> 101(2) 113–120. DOI:<a href=\"https://doi.org/10.1016/s0301-2115(01)00522-x\">10.1016/s0301-2115(01)00522-x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11858883/\">https://pubmed.ncbi.nlm.nih.gov/11858883</a></p></li><li><p>Glasier, A (2002). Emergency contraception. <i>Best practice &amp; research. Clinical obstetrics &amp; gynaecology</i> 16(2) 181–191. DOI:<a href=\"https://doi.org/10.1053/beog.2002.0269\">10.1053/beog.2002.0269</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12041961/\">https://pubmed.ncbi.nlm.nih.gov/12041961</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03XB51;
